Anbogen Therapeutics

Developer of precision cancer therapeutics

placeTaipei, Taipei, Taiwan calendar_todayFounded 2019 language anbogen.com

Innovation

3 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 13 times.

YearFilings
20242
20253
20261

Social engagement

Social engagement: 423 social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include CDIB Capital Group, Maxpro Ventures, Taian Biotechnology.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%

Recent activity

13 Apr 2026
Event
AACR Annual Meeting 2026
4 Aug 2025
Milestone
regulatory
29 Jul 2025
Recognition
Coming soon